PF-06821497, Tablet to match Placebo for PF-06821497 250mg, PF-06821497, ENZALUTAMIDE, Tablet to match Placebo for PF-06821497 125mg
C2321003
Phase 3 small_molecule active
Quick answer
PF-06821497, Tablet to match Placebo for PF-06821497 250mg, PF-06821497, ENZALUTAMIDE, Tablet to match Placebo for PF-06821497 125mg for METASTATIC CASTRATION RESISTANT PROSTATE CANCER is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- METASTATIC CASTRATION RESISTANT PROSTATE CANCER
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active